Study Of Perennial Allergic Rhinitis

Rhinitis, Allergic, Seasonal Clinical Trial

Official title:

Study of Perennial Allergic Rhinitis -Long Term Treatment Study-

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00358475
• Other study ID #: FFR100688
• Status: Completed
• Phase: Phase 3
• Start date: June 21, 2005
• Est. completion date: October 12, 2005

Study information

• Verified date: August 2018
• Source: GlaxoSmithKline
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65
• Est. completion date: October 12, 2005
• Est. primary completion date: October 1, 2005
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion criteria:

• Informed consent.

• Outpatient.

• Diagnosis of perennial allergic rhinitis with symptoms.

• Able to comply with study procedures.

Exclusion criteria:

• Significant concomitant medical condition.

• Use of corticosteroids/allergy medications.

• Laboratory abnormality.

• Positive pregnancy test.

Related Conditions & MeSH terms

• Rhinitis
• Rhinitis, Allergic
• Rhinitis, Allergic, Perennial
• Rhinitis, Allergic, Seasonal

Intervention

Drug:
• GW685698

Locations

Country	Name	City	State
	GSK Investigational Site

Sponsors (1)

Lead Sponsor	Collaborator
GlaxoSmithKline

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adverse events and laboratory blood test
Secondary	Change of nasal symptom score